Treatment related secondary malignancy
(UMLS:C0877578)
- UMLS ID:
- C0877578
- MeSH ID:
- N/A
Synonym(s)
1.
Treatment related secondary malignancy
2.
Iatrogenic Cancer
3.
Therapy Related Cancer
4.
Therapy Related Malignant Neoplasm
5.
Therapy Related Malignant Tumor
6.
Therapy-Related Malignant Neoplasm
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hydroxyurea | FAERS: 7 | OFFSIDES US FAERS | |
| 2 | Methotrexate | FAERS: 3 | OFFSIDES US FAERS | |
| 3 | Cyclophosphamide | FAERS: 2 | OFFSIDES US FAERS | |
| 4 | Mitoxantrone | FAERS: 2 | US FAERS | |
| 5 | Vemurafenib | FAERS: 2 | US FAERS | |
| 6 | fludarabine phosphate | FAERS: 2 | OFFSIDES US FAERS | |
| 7 | Bleomycin | FAERS: 1 | OFFSIDES US FAERS | |
| 8 | Bortezomib | FAERS: 1 | US FAERS | |
| 9 | Dexrazoxane | FAERS: 1 | US FAERS | |
| 10 | Docetaxel | FAERS: 1 | US FAERS | |
| 11 | Ifosfamide | FAERS: 1 | OFFSIDES US FAERS | |
| 12 | Lenalidomide | FAERS: 1 | US FAERS | |
| 13 | Megestrol Acetate | FAERS: 1 | US FAERS | |
| 14 | Mitomycin | FAERS: 1 | OFFSIDES US FAERS | |
| 15 | Mitoxantrone | FAERS: 1 | OFFSIDES US FAERS | |
| 16 | Paclitaxel | FAERS: 1 | US FAERS | |
| 17 | Bleomycin | OFFSIDES | ||
| 18 | Carboplatin | OFFSIDES | ||
| 19 | Cladribine | OFFSIDES | ||
| 20 | Cortisone | OFFSIDES | ||
| 21 | Cytarabine | OFFSIDES | ||
| 22 | Dacarbazine | OFFSIDES | ||
| 23 | Dactinomycin | OFFSIDES | ||
| 24 | Daunorubicin | OFFSIDES | ||
| 25 | Etoposide | OFFSIDES | ||
| 26 | Fluorouracil | OFFSIDES | ||
| 27 | Melphalan | OFFSIDES | ||
| 28 | Mercaptopurine | OFFSIDES | ||
| 29 | Pamidronate | OFFSIDES | ||
| 30 | Penicillin G | OFFSIDES | ||
| 31 | Procarbazine | OFFSIDES | ||
| 32 | Thioguanine | OFFSIDES | ||
| 33 | Thiotepa | OFFSIDES | ||
| 34 | Vinblastine | OFFSIDES | ||
| 35 | Vincristine | OFFSIDES | ||
| 36 | Vindesine | OFFSIDES | ||
| 37 | dexamethasone 21-phosphate | OFFSIDES | ||
| 38 | fludarabine | OFFSIDES | ||
| 39 | gemcitabine | OFFSIDES | ||
| 40 | irsogladine | OFFSIDES | ||
| 41 | nedaplatin | OFFSIDES | ||
| 42 | nilvadipine | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.